Purdue Pharma debtors see $36 million operating profit for March

By Sarah Lizee

Olympia, Wash., April 24 – Purdue Pharma LP and affiliated debtors reported a $36 million operating profit for March on $69 million of net sales, according to a monthly operating report filed Wednesday with the U.S. Bankruptcy Court for the Southern District of New York.

The net profit for March was $38 million.

The companies listed $1.35 billion in cash and cash equivalents at the end of March.

Purdue Pharma is a Stamford, Conn.-based drug manufacturer. It filed for Chapter 11 bankruptcy on Sept. 15, 2019 under case number 19-23649.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.